- Home
- Publications
- Publication Search
- Publication Details
Title
Genotype-Based Dosing Algorithms for Warfarin Therapy
Authors
Keywords
-
Journal
Molecular Diagnosis & Therapy
Volume 15, Issue 5, Pages 255-264
Publisher
Springer Nature
Online
2012-08-17
DOI
10.1007/bf03256417
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cost-Effectiveness of Using Pharmacogenetic Information in Warfarin Dosing for Patients With Nonvalvular Atrial Fibrillation
- (2013) Mark H. Eckman ANNALS OF INTERNAL MEDICINE
- The Business Case for Quality Improvement
- (2011) Adam J. Rose et al.
- Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing
- (2011) J A Johnson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Missing Association: Sequencing-Based Discovery of Novel SNPs in VKORC1 and CYP2C9 That Affect Warfarin Dose in African Americans
- (2011) M A Perera et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Significance of Combined CYP2C9 and VKORC1 Genotypes in Japanese Patients Requiring Warfarin
- (2011) You Miyagata et al. International Heart Journal
- High Doses of Clopidogrel to Overcome Genetic Resistance
- (2011) Jean-Philippe Collet et al. JACC-Cardiovascular Interventions
- Upper Limits of Physiological Cardiac Adaptation in Ultramarathon Runners
- (2011) Keith P. George et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Genetic Warfarin Dosing
- (2011) Brian S. Finkelman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Predicting the warfarin maintenance dose in elderly inpatients at treatment initiation: accuracy of dosing algorithms incorporating or not VKORC1/CYP2C9 genotypes
- (2011) C. MOREAU et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Proton pump inhibitors, genetic polymorphisms and response to clopidogrel therapy
- (2011) Himawan Fernando et al. THROMBOSIS AND HAEMOSTASIS
- Integration of Genetic, Clinical, and INR Data to Refine Warfarin Dosing
- (2010) P Lenzini et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Genetic and Clinical Predictors of Warfarin Dose Requirements in African Americans
- (2010) L H Cavallari et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Long and Winding Road to Warfarin Pharmacogenetic Testing**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.
- (2010) Geoffrey S. Ginsburg et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Warfarin Genotyping Reduces Hospitalization Rates
- (2010) Robert S. Epstein et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- An evaluation of nine genetic variants related to metabolism and mechanism of action of warfarin as applied to stable dose prediction
- (2010) John F. Carlquist et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Structure of a bacterial homologue of vitamin K epoxide reductase
- (2010) Weikai Li et al. NATURE
- VKORC1,CYP2C9andCYP4F2genetic-based algorithm for warfarin dosing: an Italian retrospective study
- (2010) Carlo-Federico Zambon et al. PHARMACOGENOMICS
- Influence of CYP2C9 and VKORC1 on warfarin response during initiation of therapy
- (2009) N.A. Limdi et al. BLOOD CELLS MOLECULES AND DISEASES
- Interactive Modeling for Ongoing Utility of Pharmacogenetic Diagnostic Testing: Application for Warfarin Therapy
- (2009) M. W. Linder et al. CLINICAL CHEMISTRY
- Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy
- (2009) N. S. FERDER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- A Policy Model to Evaluate the Benefits, Risks and Costs of Warfarin Pharmacogenomic Testing
- (2009) Lisa M. Meckley et al. PHARMACOECONOMICS
- Validation of VKORC1 and CYP2C9 genotypes on interindividual warfarin maintenance dose: a prospective study in Chinese patients
- (2009) Sheng-Wen Huang et al. Pharmacogenetics and Genomics
- Relative contribution of CYP2C9 and VKORC1 genotypes and early INR response to the prediction of warfarin sensitivity during initiation of therapy
- (2008) C. Li et al. BLOOD
- CYP4F2 genetic variant alters required warfarin dose
- (2008) M. D. Caldwell et al. BLOOD
- The largest prospective warfarin-treated cohort supports genetic forecasting
- (2008) M. Wadelius et al. BLOOD
- Pharmacology and Management of the Vitamin K Antagonists
- (2008) Jack Ansell et al. CHEST
- Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin
- (2008) BF Gage et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Dosing Algorithms to Predict Warfarin Maintenance Dose in Caucasians and African Americans
- (2008) H Schelleman et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Laboratory and clinical outcomes of pharmacogenetic vs. clinical protocols for warfarin initiation in orthopedic patients
- (2008) P. A. LENZINI et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Dosing anticoagulant therapy with coumarin drugs: is genotyping clinically useful? No
- (2008) P. M. MANNUCCI et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Dosing anticoagulant therapy with coumarin drugs: is genotyping clinically useful? Yes
- (2008) S. M. THACKER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Genetic Determinants of Response to Warfarin during Initial Anticoagulation
- (2008) Ute I. Schwarz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Influence ofCYP2C9andVKORC1on warfarin dose, anticoagulation attainment and maintenance among European–Americans and African–Americans
- (2008) Nita A Limdi et al. PHARMACOGENOMICS
- Warfarin Pharmacogenetics
- (2008) Nita A Limdi et al. PHARMACOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search